FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1959763606> ?p ?o ?g. }

• W1959763606 endingPage "553.e2" @default.
• W1959763606 startingPage "540" @default.
• W1959763606 abstract "Droplet digital polymerase chain reaction (ddPCR), which could perform thousands of PCRs on a nanoliter scale simultaneously, would be an attractive method to massive parallel sequencing for identifying and studying the significance of low-frequency rare mutations. Recent evidence has shown that the key potential mechanisms of the failure of aromatase inhibitors–based therapy involve identifying activating mutations affecting the ligand-binding domain of the ESR1 gene. Therefore, the detection of ESR1 mutations may be useful as a biomarker predicting an effect of the treatment. We aimed to develop a ddPCR-based method for the sensitive detection of ESR1 mutations in 325 breast cancer specimens, in which 270 primary and 55 estrogen receptor–positive (ER+) metastatic breast cancer (MBC) specimens. Our ddPCR assay could detect the ESR1 mutant molecules with low concentration of 0.25 copies/μL. According to the selected cutoff, ESR1 mutations occurred in 7 (2.5%) of 270 primary breast cancer specimens and in 11 (20%) of 55 ER+ MBC specimens. Among the 11 MBC specimens, 5 specimens (45.5%) had the most common ESR1 mutation, Y537S, 4 specimens (36.3%) each had D538G, Y537N, and Y537C. Interestingly, 2 patients had 2 ESR1 mutations, Y537N/D538G and Y537S/Y537C, and 2 patients had 3 ESR1 mutations, Y537S/Y537N/D538G. Biopsy was performed in heterochrony in 8 women twice. In 8 women, 4 women had primary breast cancer and MBC specimens and 4 women had 2 specimens when treatment was failure. Four of these 8 women acquired ESR1 mutation, whereas no ESR1 mutation could be identified at first biopsy. ddPCR technique could be a promising tool for the next-generation sequencing-free precise detection of ESR1 mutations in endocrine therapy resistant cases and may assist in determining the treatment strategy. Droplet digital polymerase chain reaction (ddPCR), which could perform thousands of PCRs on a nanoliter scale simultaneously, would be an attractive method to massive parallel sequencing for identifying and studying the significance of low-frequency rare mutations. Recent evidence has shown that the key potential mechanisms of the failure of aromatase inhibitors–based therapy involve identifying activating mutations affecting the ligand-binding domain of the ESR1 gene. Therefore, the detection of ESR1 mutations may be useful as a biomarker predicting an effect of the treatment. We aimed to develop a ddPCR-based method for the sensitive detection of ESR1 mutations in 325 breast cancer specimens, in which 270 primary and 55 estrogen receptor–positive (ER+) metastatic breast cancer (MBC) specimens. Our ddPCR assay could detect the ESR1 mutant molecules with low concentration of 0.25 copies/μL. According to the selected cutoff, ESR1 mutations occurred in 7 (2.5%) of 270 primary breast cancer specimens and in 11 (20%) of 55 ER+ MBC specimens. Among the 11 MBC specimens, 5 specimens (45.5%) had the most common ESR1 mutation, Y537S, 4 specimens (36.3%) each had D538G, Y537N, and Y537C. Interestingly, 2 patients had 2 ESR1 mutations, Y537N/D538G and Y537S/Y537C, and 2 patients had 3 ESR1 mutations, Y537S/Y537N/D538G. Biopsy was performed in heterochrony in 8 women twice. In 8 women, 4 women had primary breast cancer and MBC specimens and 4 women had 2 specimens when treatment was failure. Four of these 8 women acquired ESR1 mutation, whereas no ESR1 mutation could be identified at first biopsy. ddPCR technique could be a promising tool for the next-generation sequencing-free precise detection of ESR1 mutations in endocrine therapy resistant cases and may assist in determining the treatment strategy. Takashi Takeshita, PhD, is an Assistant Professor in the Department of Breast and Endocrine Surgery in the Graduate School of Medical Science at Kumamoto University. Dr. Takeshita's research interests are in the development of non-invasive biomarkers, in particular, cell-free DNA." @default.
• W1959763606 created "2016-06-24" @default.
• W1959763606 creator A5002884489 @default.
• W1959763606 creator A5018788633 @default.
• W1959763606 creator A5024725726 @default.
• W1959763606 creator A5035071748 @default.
• W1959763606 creator A5072041984 @default.
• W1959763606 creator A5087154078 @default.
• W1959763606 creator A5087891477 @default.
• W1959763606 creator A5090403107 @default.
• W1959763606 date "2015-12-01" @default.
• W1959763606 modified "2023-10-09" @default.
• W1959763606 title "Droplet digital polymerase chain reaction assay for screening of ESR1 mutations in 325 breast cancer specimens" @default.
• W1959763606 cites W1453600927 @default.
• W1959763606 cites W1881707187 @default.
• W1959763606 cites W1970797634 @default.
• W1959763606 cites W1979630663 @default.
• W1959763606 cites W1979946545 @default.
• W1959763606 cites W2021145743 @default.
• W1959763606 cites W2024415595 @default.
• W1959763606 cites W2042194227 @default.
• W1959763606 cites W2064543601 @default.
• W1959763606 cites W2073367400 @default.
• W1959763606 cites W2081538666 @default.
• W1959763606 cites W2082887122 @default.
• W1959763606 cites W2111324624 @default.
• W1959763606 cites W2113559596 @default.
• W1959763606 cites W2118135682 @default.
• W1959763606 cites W2123129045 @default.
• W1959763606 cites W2123950418 @default.
• W1959763606 cites W2124358769 @default.
• W1959763606 cites W2133344765 @default.
• W1959763606 cites W2140575188 @default.
• W1959763606 cites W2144806347 @default.
• W1959763606 cites W2150757282 @default.
• W1959763606 cites W2154220735 @default.
• W1959763606 cites W2156604663 @default.
• W1959763606 cites W2158038535 @default.
• W1959763606 cites W2163814095 @default.
• W1959763606 cites W2579829632 @default.
• W1959763606 doi "https://doi.org/10.1016/j.trsl.2015.09.003" @default.
• W1959763606 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26434753" @default.
• W1959763606 hasPublicationYear "2015" @default.
• W1959763606 type Work @default.
• W1959763606 sameAs 1959763606 @default.
• W1959763606 citedByCount "52" @default.
• W1959763606 countsByYear W19597636062016 @default.
• W1959763606 countsByYear W19597636062017 @default.
• W1959763606 countsByYear W19597636062018 @default.
• W1959763606 countsByYear W19597636062019 @default.
• W1959763606 countsByYear W19597636062020 @default.
• W1959763606 countsByYear W19597636062021 @default.
• W1959763606 countsByYear W19597636062022 @default.
• W1959763606 countsByYear W19597636062023 @default.
• W1959763606 crossrefType "journal-article" @default.
• W1959763606 hasAuthorship W1959763606A5002884489 @default.
• W1959763606 hasAuthorship W1959763606A5018788633 @default.
• W1959763606 hasAuthorship W1959763606A5024725726 @default.
• W1959763606 hasAuthorship W1959763606A5035071748 @default.
• W1959763606 hasAuthorship W1959763606A5072041984 @default.
• W1959763606 hasAuthorship W1959763606A5087154078 @default.
• W1959763606 hasAuthorship W1959763606A5087891477 @default.
• W1959763606 hasAuthorship W1959763606A5090403107 @default.
• W1959763606 hasConcept C104317684 @default.
• W1959763606 hasConcept C121608353 @default.
• W1959763606 hasConcept C126322002 @default.
• W1959763606 hasConcept C143998085 @default.
• W1959763606 hasConcept C172313692 @default.
• W1959763606 hasConcept C2781197716 @default.
• W1959763606 hasConcept C48126324 @default.
• W1959763606 hasConcept C49105822 @default.
• W1959763606 hasConcept C501734568 @default.
• W1959763606 hasConcept C502942594 @default.
• W1959763606 hasConcept C530470458 @default.
• W1959763606 hasConcept C54355233 @default.
• W1959763606 hasConcept C71924100 @default.
• W1959763606 hasConcept C84606932 @default.
• W1959763606 hasConcept C86803240 @default.
• W1959763606 hasConceptScore W1959763606C104317684 @default.
• W1959763606 hasConceptScore W1959763606C121608353 @default.
• W1959763606 hasConceptScore W1959763606C126322002 @default.
• W1959763606 hasConceptScore W1959763606C143998085 @default.
• W1959763606 hasConceptScore W1959763606C172313692 @default.
• W1959763606 hasConceptScore W1959763606C2781197716 @default.
• W1959763606 hasConceptScore W1959763606C48126324 @default.
• W1959763606 hasConceptScore W1959763606C49105822 @default.
• W1959763606 hasConceptScore W1959763606C501734568 @default.
• W1959763606 hasConceptScore W1959763606C502942594 @default.
• W1959763606 hasConceptScore W1959763606C530470458 @default.
• W1959763606 hasConceptScore W1959763606C54355233 @default.
• W1959763606 hasConceptScore W1959763606C71924100 @default.
• W1959763606 hasConceptScore W1959763606C84606932 @default.
• W1959763606 hasConceptScore W1959763606C86803240 @default.
• W1959763606 hasFunder F4320320912 @default.
• W1959763606 hasIssue "6" @default.
• W1959763606 hasLocation W19597636061 @default.
• W1959763606 hasOpenAccess W1959763606 @default.
• W1959763606 hasPrimaryLocation W19597636061 @default.

• next